Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study (Q46616101)
Jump to navigation
Jump to search
scientific article published in May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study |
scientific article published in May 2008 |
Statements
1 reference
Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study (English)
1 reference
Dominik R Berthold
1 reference
Gregory R Pond
1 reference
Martin Roessner
1 reference
Ronald de Wit
1 reference
Mario Eisenberger
1 reference
And Ian F Tannock
1 reference
TAX-327 investigators
1 reference
1 May 2008
1 reference
14
1 reference
9
1 reference
2763-2767
1 reference